Related Experiment Video
Updated: Aug 11, 2026

Real-time Live Imaging of T-cell Signaling Complex Formation
Published on: June 23, 2013
Convergence between CD98 and integrin-mediated T-lymphocyte co-stimulation
A P Warren1, K Patel, Y Miyamoto
1Department of Biochemistry, St George's Hospital Medical School, London, UK.
Insights
The cell surface molecule CD98 (also known as solute carrier 3A2) plays a key role in T lymphocyte activation. Blocking beta1 integrin signaling inhibits CD98 co-stimulatory activity, suggesting convergent signaling pathways.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- CD98 is a heterodimeric glycoprotein expressed on the cell surface.
- It is rapidly upregulated upon T lymphocyte activation.
- Monoclonal antibody (mAb) 80A10 recognizes an epitope on CD98.
Purpose of the Study:
- To investigate the co-stimulatory activity of CD98.
- To determine the effect of beta1 integrin-blocking antibodies on CD98 co-stimulation.
- To explore potential convergent signaling mechanisms between CD98 and integrins.
Main Methods:
- Using monoclonal antibodies (mAbs) 80A10 and 4F2 to target CD98.
- Employing CD3 antibody to induce T lymphocyte proliferation.
- Utilizing soluble beta1 integrin antibody 18D3 to block integrin function.
- Comparing the effects of 18D3 on CD98 and other non-integrin co-stimulatory molecules.
Main Results:
- mAb 80A10 in combination with CD3 antibody induced proliferation of peripheral blood T lymphocytes.
- CD98 co-stimulatory activity (mediated by mAb 80A10 or 4F2) was blocked by the soluble beta1 integrin antibody 18D3.
- Previously, 18D3 was shown to inhibit co-stimulatory activity of specific integrins (alpha4beta1, alpha5beta1, alphaLbeta2, alpha4beta7) but not other non-integrins.
- CD98 demonstrated unique sensitivity to beta1 integrin-blocking antibodies.
Conclusions:
- CD98 is uniquely sensitive to inhibitory effects of beta1 integrin-blocking antibodies.
- This sensitivity suggests convergent signaling mechanisms between integrins and CD98.
- CD98 may play a role in regulating integrin-mediated adhesive events.
Abstract:
CD98 is a widely expressed cell surface heterodimeric glycoprotein, which is rapidly up-regulated upon activation of T lymphocytes. Monoclonal antibody (mAb) 80A10 recognizes an epitope on CD98 and in combination with CD3 antibody causes proliferation of peripheral blood T lymphocytes. CD98 co-stimulatory activity, mediated by either mAb 80A10 or 4F2, a well-characterized CD98-specific mAb, is blocked in the presence of the soluble beta1 integrin antibody 18D3. Previously we have reported that co-stimulatory activity of antibodies to integrins alpha4beta1, alpha5beta1, alphaLbeta2 and alpha4beta7 is inhibited by 18D3, whereas co-stimulation mediated by non-integrins was unaffected. Thus the non-integrin CD98 is uniquely sensitive to the inhibitory effects of beta1 integrin-blocking antibodies, which may reflect convergent signalling mechanisms between integrins and CD98. This is consistent with recent reports suggesting that CD98 may regulate integrin-mediated adhesive events.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

